| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.55 | 0.05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |